Senior insider sale
See Remarks at XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$432.6K
60K shares
What this filing means
MCCULLOCH KEVIN plans to sell 60K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $432.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/8/2026ACC: 0001950047-26-000273
Officer· See Remarks
Since Mar 2026
60K
Shares to sell
$432.6K
Approx. market value
60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/31/2021
60KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2021 | Restricted Stock Units N/A | 60K | — |
| Total | 60K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
60K
Market value
$432.6K
1/8/2026
Total
Units
60K
Value
$432.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/8/2026 | 60K | $432.6K | NASDAQ | Planned |
| Total | 60K | $432.6K | ||